Illegal Activity
none
Blackmail
none
Date
2014-04-16
Document Type
other
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:43
Summary
This document is a snapshot of an investment portfolio as of April 16, 2014, detailing holdings in biotech companies like Sangamo Biosciences, Biogen, Foundation Medicine, Gilead Sciences, and Ariad Pharmaceuticals. It lists quantities, prices, costs, and unrealized gains/losses for each stock.
Metadata
- Subject
- Investment Portfolio
- Sender
- —
- Recipients
- —
- Document ID
- DB-SDNY-0101743 SDNY_GM_00247927
- Date
- 2014-04-16
Financial Information
Amounts:14.128.44706,000.00422,214.00283,786.00290.72119.55609,058.40250,454.95358,603.4527.2727.51681,625.00687,663.50(6,038.50)69.3179.41561,402.90643,204.00(81,801.10)2,558,086.302,003,536.45554,549.856.8317.60112,934.05290,997.40(178,063.35)
Assets:
- SANGAMO BIOSCIENCES
- BIOGEN
- FOUNDATION MEDICINE
- GILEAD SCIENCES INC
- ARIAD PHARMACEUTICALS
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flow
Organizations 5
SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS
Text Analysis
- Tone
- Informative
- Purpose
- To provide a snapshot of an investment portfolio's performance as of April 16, 2014.
- Significance
- Shows the holdings, quantities, prices, costs, and unrealized gains/losses for various biotech stocks.
File Info
- File Name
- EFTA01447188.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:43:32.965791
- DOJ Source
- View on DOJ